Why Shares of Aurora Cannabis Continue to See Such Extreme Volatility

: ACB | Aurora Cannabis Inc. News, Ratings, and Charts

ACB – It’s been quite a week for shares of Aurora Cannabis (ACB). In just the past few days of trading, the stock was trading for just over $5 per share and has been as high as $19.

 

It’s been quite a week for shares of Aurora Cannabis (ACB). In just the past few days of trading, the stock was trading for just over $5 per share and has been as high as $19.  Currently the stock is trading just below $16.

Investors might be curious as to what is causing so much volatility.

ACB initiated a 12-for-1 reverse stock split last week after facing a delisting warning from the New York Stock Exchange, due to their share price being below $1 per share. 

Then on May 14th, ACB posted its third-quarter earnings.  They saw revenues jumping 35% from their previous quarter, which caused their shares to have a major rally.

On Monday of this week Ladenburg Thalmann reiterated their buy rating on shares of Aurora Cannabis but analyst Glenn Mattson lowered his price target to $18 per share. The firm originally had a $36 split-adjusted price target prior to the update. 

Mattson said, “We think ACB can become a solid cash flow generator simply from the Canadian operations and, with a strong market position in Canada, the company can create significant value from here based on this one market. We do think that it will look to expand into the U.S. but not until federal legality is more clear.” 

Short-sellers have been capitalizing on the downtrend in ACB for some time now but were caught by surprise with this earnings release.  As a result, short-sellers covering their trades have played a large part in this dramatic rally.

Next quarter should ultimately determine the future for ACB.  We will be watching closely for further write-downs along with how efficient that is in terms of SG&A cost-cutting. ACB has promised a profitable Q1 2021 quarter due to their debt covenants so this really needs to happen if ACB wants to maintain shareholder confidence.

(Disclosure: The author is long ACB)

Want More Great Investing Ideas?

9 “BUY THE DIP” Growth Stocks for 2020

7 “Safe-Haven” Dividend Stocks for Turbulent Times

REVISED 2020 Stock Market Outlook– Discover why there is more downside ahead and the Top 10 picks for the bear market.

 

 


ACB shares were trading at $15.42 per share on Tuesday afternoon, down $1.68 (-9.82%). Year-to-date, ACB has declined -40.51%, versus a -7.72% rise in the benchmark S&P 500 index during the same period.


About the Author: Aaron Missere


Aaron is an experienced investor who is also the CEO of Departures Capital. His primary focus is on the cannabis industry. He also hosts a weekly show on YouTube about marijuana stocks. Learn more about Aaron’s background, along with links to his most recent articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
ACBGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

2 Best Stocks of All Time!

This bear market has me thinking back to my 2 best trades of all time. That being when I bought Amazon (AMZN) and Booking (BKNG) back in 2001 as they were tumbling down in the midst of a bear market...but now enjoying truly phenomenal gains. Let’s discuss what those investments had in common and how that will help us find more big winners in the years ahead. Read on below for more...

:  |  News, Ratings, and Charts

Bears Back in Charge...What Happens Next?

A month ago the bulls were claiming victory as they created a charge back over 4,000 for the S&P 500 (SPY). Since then that false narrative has been peeled away and investors are more honestly looking at the bleak outlook formed by high inflation and a hawkish Fed. That explains why we are back retesting the June lows. Now we have to ponder what comes next and how to trade our way to profits. Read on below for the full story...

:  |  News, Ratings, and Charts

3 Healthcare Stocks Under $100 to Buy Right Now

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK), and Bristol-Myers Squibb (BMY), which are currently trading under $100. Read on…

:  |  News, Ratings, and Charts

Cut These 2 Stocks From Your Portfolio Right Now

The Fed succeeding in a ‘soft landing’ seems unlikely. Analysts are expecting a recession soon. So, with the rising odds of the Fed raising rates aggressively, it could be wise to steer clear of fundamentally weak stocks Roblox (RBLX) and Affirm Holdings (AFRM). Read on…

:  |  News, Ratings, and Charts

3 Healthcare Stocks Under $100 to Buy Right Now

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK), and Bristol-Myers Squibb (BMY), which are currently trading under $100. Read on…

Read More Stories

More Aurora Cannabis Inc. (ACB) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ACB News